You are here

  • Home
  • Archive
  • Volume 81, Issue 1
  • B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial

Article metrics

Article menu
Systemic lupus erythematosus
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial

 

Online download statistics by month:

Online download statistics by month: October 2021 to August 2024

AbstractFullPdf
Oct 202116191591921
Nov 202112551229735
Dec 2021841826373
Jan 202218591853807
Feb 2022847842468
Mar 202210731040601
Apr 2022874881469
May 2022741750363
Jun 2022873874419
Jul 2022712698282
Aug 2022711709346
Sep 2022876865390
Oct 2022888884391
Nov 2022870823380
Dec 2022635623284
Jan 2023704669346
Feb 2023723699337
Mar 2023869840391
Apr 2023769757388
May 2023845810392
Jun 2023818784399
Jul 202312371220383
Aug 2023677656328
Sep 2023733712302
Oct 2023943923368
Nov 202311661140479
Dec 2023796775390
Jan 2024571523354
Feb 2024756672396
Mar 2024980962550
Apr 202411991183540
May 2024961946493
Jun 2024865849445
Jul 202412651243532
Aug 202411431129499
Total326943198015541